Coya Therapeutics Inc. (NASDAQ: COYA) Stock Information | RedChip

Coya Therapeutics Inc. (NASDAQ: COYA) Listen to this Section


$5.07
+0.0600 ( +1.20% ) 46.9K

Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.

Market Data


Open


$5.07

Previous close


$5.01

Volume


46.9K

Market cap


$77.93M

Day range


$5.01 - $5.34

52 week range


$3.21 - $10.69

Insider Ownership Transactions

Total Amount Purchased: -672,173.00 | $ -3,407,917.11

Date Type Amount Purchased Purchaser
2024-06-05 Sale -70596.00 Grossman Fred
2024-06-05 Sale -163663.00 Berman Howard
2024-06-05 Sale -70596.00 SNYDER DAVID S
2024-03-05 Buy 1000.00 Lee Ann
2024-02-02 Sale -189680.00 Berman Howard
2024-02-02 Sale -81819.00 Grossman Fred
2024-02-02 Sale -81819.00 SNYDER DAVID S
2024-01-19 Sale -5000.00 Lee Ann
2024-01-19 Sale -5000.00 GOLDSTEIN DOV A MD
2024-01-19 Sale -5000.00 Garren Hideki

SEC Fillings


Form Type Description Pages Date
10-q Quarterly Reports 55 Aug 12, 2024
8-k 8K-related 12 Aug 12, 2024
8-k 8K-related 13 Jul 15, 2024
8-k 8K-related 14 Jun 05, 2024
4 Insider transactions 1 Jun 05, 2024
4 Insider transactions 1 Jun 05, 2024
4 Insider transactions 1 Jun 05, 2024
8-k 8K-related 15 May 20, 2024
10-q Quarterly Reports 51 May 09, 2024
8-k 8K-related 12 May 09, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.